| dc.creator |
Sezer, MT |
|
| dc.creator |
Ertugrul, C |
|
| dc.creator |
Sarikaya, M |
|
| dc.creator |
Ersoy, FF |
|
| dc.creator |
Isitan, F |
|
| dc.creator |
Suleymanlar, G |
|
| dc.creator |
Tuncer, M |
|
| dc.creator |
Suleymanlar, I |
|
| dc.creator |
Yakupoglu, G |
|
| dc.date |
1999-01-01T01:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:29:01Z |
|
| dc.date.available |
2021-12-03T11:29:01Z |
|
| dc.identifier |
5820af6f-d7b2-4395-974a-20db488cc49b |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/5820af6f-d7b2-4395-974a-20db488cc49b/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/91985 |
|
| dc.description |
In this study: the response to triple treatment,with omeprazole, amoxicillin, and clarithromycin was investigated irt continuous ambulatory peritoneal dialysis (CAPD) patients with Helicobacter pylori (Hp) infections. The study enrolled 20 CAPD patients (11 male, 9female) who had dyspeptic complaints. The mean age of the patients,vas 46 (range: 21-65). The stud!: also enrolled, as a control group, 124 patients (66 male, 58 female) who had no systemic disease, but who had upper gastrointestinal endoscopy for dyspeptic complaints. The mean age of the patients in the control group was 47 years (range: 20 - 74 years). |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients |
|
| dc.type |
info:eu-repo/semantics/conferenceObject |
|